Systemic Lupus Erythematosus Prevalence in Sweden in 2010: What Do National Registers Say?

Arthritis Care and Research

Volumn 66, Issue 11, 2014, Pages 1710-1717

  Simard, Julia F ^a,b   Sjöwall, Christopher ^c   Rönnblom, Lars ^d   Jönsen, Andreas ^e   Svenungsson, Elisabet ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LINKÖPING UNIVERSITY   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; MYCOPHENOLATE MOFETIL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOLOGY; DISEASE REGISTRY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; NEPHROLOGY; PREVALENCE; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SWEDEN; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 85007206669     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22355     Document Type: Article

References (17)

1. Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 2006;15:308–18.
2. Neovius M, Simard JF, Askling J. Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden. Ann Rheum Dis 2011;70:624–9.
3. Lofstrom B, Backlin C, Sundstrom C, Hellstrom-Lindberg E, Ekbom A, Lundberg IE. Myeloid leukaemia in systemic lupus erythematosus: a nested case-control study based on Swedish registers. Rheumatology (Oxford) 2009;48:1222–6.
4. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Euro J Epidemiol 2009;24:659–67.
5. Statistics Sweden. Maps and regional analysis. Statistiska centralbyrån; 2012. URL: http://www.scb.se/statistikatlasen.
6. Swedish Rheumatology Association. Tidskrift för Svensk Reumatologisk Förening. 2009. URL: http://www.svenskreumatologi.se/.
7. Lofstrom B, Backlin C, Sundstrom C, Ekbom A, Lundberg IE. A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study. Ann Rheum Dis 2007;66:1627–32.
8. Lerang K, Gilboe I, Garen T, Thelle DS, Gran JT. High incidence and prevalence of systemic lupus erythematous in Norway. Lupus 2012;21:1362–9.
9. Nived O, Sturfelt G, Wollheim F. Systemic lupus erythematosus in an adult population in southern Sweden: incidence, prevalence and validity of ARA revised classification criteria. Brit J Rheumatol 1985;24:147–54.
10. Stahl-Hallengren C, Jonsen A, Nived O, Sturfelt G. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol 2000;27:685–91.
11. Bernatsky S, Joseph L, Pineau CA, Tamblyn R, Feldman DE, Clarke AE. A population-based assessment of systemic lupus erythematosus incidence and prevalence: results and implications of using administrative data for epidemiological studies. Rheumatology (Oxford) 2007;46:1814–8.
12. Ward MM. Prevalence of physician-diagnosed systemic lupus erythematosus in the United States: results from the third National Health and Nutrition Examination Survey. J Womens Health (Larchmt) 2004;13:713–8.
13. Somers EC, Marder W, Cagnoli P, Lewis EE, Deguire P, Gordon C, et al. Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance Program. Arthritis Rheumatol 2014;66:369–78.
14. Lim SS, Bayakly AR, Helmick CG, Gordon C, Easley KA, Drenkard C. The incidence and prevalence of systemic lupus erythematosus, 2002–2004: the Georgia Lupus Registry. Arthritis Rheumatol 2014;66:357–68.
15. Yurkovich M, Vostretsova K, Chen W, Avina-Zubieta JA. Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care Res (Hoboken) 2014;66:608–16.
16. Gustafsson JT, Simard JF, Gunnarsson I, Elvin K, Lundberg IE, Hansson LO, et al. Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus: a prospective cohort study. Arthritis Res Ther 2012;14:R46.
17. Lerang K, Garen T, Gilboe IM, Gran JT. Mortality in systemic lupus erythematosus compared to the general population [abstract].Lupus 2013; Suppl 1:1–196. Proceedings of the 10th International Congress on SLE; 2013 Apr 18–21, Buenos Aires, Argentina.